Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 9:47 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 56 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Dental Impaction Clear all

Conditions: Environmental Exposure
Interventions: Nutrition; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 80 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Dental Pain
Interventions: N1539, placebo, Motrin; Drug
Lead sponsor: Alkermes, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 230 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Adverse Childhood Experiences, Family Functioning
Interventions: Garnering Resilience in Traumatized youth and families (GRIT), Digital Citizenship Curriculum (DCC); Behavioral
Lead sponsor: University of California, Irvine; Other
Eligibility: 11 Years to 14 Years
Enrollment: 210 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Irvine, California

Conditions: Asthma
Interventions: PARTICS using QVAR; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 1,220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 19
States / cities: Birmingham, Alabama • Los Angeles, California • Denver, Colorado + 14 more

Conditions: Dental Pain
Interventions: Naproxen Test, Naprosyn, Placebo; Drug
Lead sponsor: Iroko Pharmaceuticals, LLC; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 254 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Spinal Cord Injury Cervical
Interventions: Water Faucet; Device
Lead sponsor: Old Dominion University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Tooth, Impacted
Interventions: Wisdom tooth extraction; Procedure
Lead sponsor: National Institute of Nursing Research (NINR); NIH
Eligibility: Not listed
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Pain
Interventions: Ibuprofen 300 mg Oral Tablet, Ibuprofen 200 mg Oral Tablet, Placebo of PR tablet, Placebo of IR tablet; Drug
Lead sponsor: Reckitt Benckiser Healthcare (UK) Limited; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Spinal Cord Injuries
Interventions: Water Faucet; Device
Lead sponsor: Old Dominion University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Opioid-Related Disorders, Substance-Related Disorders, Intimate Partner Violence (IPV), Stress Disorders, Post-Traumatic, Domestic Violence, Medication for Opioid Use Disorder (MOUD), Post Traumatic Stress Disorder PTSD
Interventions: Pre-Pilot WINGS++++; Behavioral
Lead sponsor: Dawn A. Goddard-Eckrich; Other
Eligibility: 18 Years and older · Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: New York, New York • Newburgh, New York

Conditions: Angina Pectoris, Coronary Artery Disease, Chest Pain, Cardiovascular Diseases, Coronary Heart Disease, CAD, CVD, CHD
Interventions: Corus CAD (ASGES); Diagnostic Test
Lead sponsor: CardioDx; Industry
Eligibility: 21 Years to 99 Years
Enrollment: 171 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Obstetric Labor Complications, Cesarean Section
Interventions: Quality Improvement Project; Other
Lead sponsor: HealthPartners Institute; Other
Eligibility: Not listed
Enrollment: 409 participants
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Cerumen Impaction of Both Ears
Interventions: E002 - cerumen removal aid; Device
Lead sponsor: Dr. Joseph Griffin; Industry
Eligibility: 40 Years and older
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Plano, Texas

Conditions: Sports Concussion
Interventions: Resveratrol, Placebo; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 35 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Pain, Postoperative
Interventions: Twin block, iPill dispenser; Drug · Device
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 133 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: HIV Infections, Alcohol Use Disorder, Violence, Gender-Based
Interventions: PrEP for WINGS, PrEP Decision Aid; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 307 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Post Operative Pain, Impacted Third Molar Tooth, Muscle Pain
Interventions: Temporo-masseteric Nerve Block Injection, Oral Pain Medications only; Drug
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Impacted Third Molar Tooth, Pain, Acute
Interventions: Ibuprofen, Acetaminophen, Placebo, Oxycodone; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 64 Years
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Impacted Third Molar Tooth, Temporomandibular Disorder
Interventions: The Restful Jaw Device; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 30 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 4
States / cities: Burnsville, Minnesota • Eden Prairie, Minnesota • Minneapolis, Minnesota + 1 more

Conditions: Impacted Wisdom Teeth
Interventions: Caldolor, Ofirmev; Drug
Lead sponsor: Tufts University School of Dental Medicine; Other
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Dental Pain
Interventions: Diclofenac Test (lower dose), Diclofenac Test (upper dose), Celecoxib 400 mg, Placebo; Drug
Lead sponsor: Iroko Pharmaceuticals, LLC; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Pain
Interventions: AZD1386, Naproxen, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 103 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Anxiety, Depression
Interventions: Acceptance-Based Behavior Therapy (ABBT), Treatment-as-Usual (TAU); Behavioral · Other
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Dental Pain
Interventions: Celecoxib 400 mg, Placebo, Indomethacin Test (lower dose), Indomethacin Test (upper dose); Drug
Lead sponsor: Iroko Pharmaceuticals, LLC; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 203 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Austin, Texas

Search by objective public record fields.

Assessing and Addressing Community Exposures to Environmental Contaminants

Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery

The THRIVE Study: Teaching Healthy Regulation in Individuals & Vulnerable Environments

Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief

Study of Naproxen Capsules to Treat Dental Pain

Access-H20: Sensor-driven Smart Faucet

Bradykinin Receptors and Pain

Efficacy of 300 mg Ibuprofen Prolonged-Release Tablets for the Treatment of Pain After Surgical Removal of Impacted Third Molars

Access-H20: Sensor-driven Smart Faucet Related Study

Pre-Pilot (R61) WINGS+++: mHealth to Improve MOUD Uptake in Women Experiencing Intimate Partner Violence and PTSD

Utility of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Cardiology Practice Pattern

Evaluation of a Quality Improvement Project on Impacted Fetal Head at Cesarean Section

Evaluation of a Novel Product for the Removal of Impacted Human Cerumen (Earwax)

Use of Resveratrol to Decrease Acute Secondary Brain Injury Following Sports-Related Concussions in Boxers

Reducing Opioid Use and Misuse After Wisdom Molar Extractions

An Effectiveness Trial of the PrEP for WINGS Study

Jaw Muscle Pain Post Wisdom Molar Surgery

Towards Predicting the Analgesic Response to Ibuprofen Following Third-molar Extraction

Assessing a New Jaw Support Device During Third Molar Extractions

Efficacy Study of IV Ibuprofen vs IV Acetaminophen Post Surgical Extraction

Study of Diclofenac Capsules to Treat Dental Pain

Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1386

Improving Mental Health Among the LGBTQ+ Community

Phase 2 Study of Indomethacin Capsules to Treat Dental Pain